Rehabilitation Clinical Trial
Official title:
Effects of High-induction Magnetic Field Therapy in Patients With Shoulder Pain
Verified date | October 2023 |
Source | KTO Karatay University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
High Induction Magnetic Field Therapy is a therapeutic method that uses high-intensity fields (up to 2.5 T) that produce high current density in exposed tissue. While there are studies in the literature on devices with 2.5 T, there is no research on the effect of 4 T. Magnetic field application contributes significantly to the healing process. It is an easier, cheaper, and more comfortable application. The magnetic field has been clinically proven to be safe. It is a practical, non-invasive method to induce cell and tissue modifications, correcting selected pathological conditions through magnetic application. The aim of the study is to investigate whether High Induction Magnetic Field therapy applied in addition to conservative treatment in patients with shoulder pain makes a difference compared to conservative treatment alone.
Status | Completed |
Enrollment | 36 |
Est. completion date | January 2, 2024 |
Est. primary completion date | January 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Voluntarily agreeing to participate in the research. - Being between the ages of 18 and 65 - Having at least one of the following diagnoses: shoulder impingement syndrome, rotator cuff rupture, and subacromial bursitis. - Having the cognitive fitness to perform the surveys and tests to be used during the research. Exclusion Criteria - Having a chronic disease such as neurological, orthopedic or cardiovascular that cannot be controlled with medication. - Not volunteering to participate in the research. - Pregnant and suspected pregnancy individuals - Individuals with pacemakers - Individuals with implantable ear hearing aids - Individuals with metallic implants |
Country | Name | City | State |
---|---|---|---|
Turkey | KTO Karatay University | Konya | Karatay |
Lead Sponsor | Collaborator |
---|---|
KTO Karatay University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual analogue scale-VAS | A score between 0 and 10 points is given and used to evaluate pain. | baseline and after 4 weeks of treatment | |
Primary | Range of Motion | Range of Motion of Shoulder Joint: Shoulder joint flexion (0-180 degrees), abduction (0-180 degrees), external rotation (0-90 degrees) and internal rotation (0-90 degrees) range of motion will be measured with a goniometer. Higher values indicate increased mobility. | baseline and after 4 weeks of treatment | |
Primary | Disabilities of the Arm, Shoulder and Hand (DASH) | The DASH is a 30-item patient-reported outcome measure utilized to assess symptoms and function of the entire upper extremity. Total scores range from 0 (minimum) to (100) maximum. The first 30 questions of the survey will be applied. As the score increases, the disability level increases. | baseline and after 4 weeks of treatment | |
Primary | Constant Murley Score | It is a 100-point scale consisting of 15 points for pain, 20 points for daily activities, 40 points for pain-free joint range of motion, and 25 points for strength parameters. While pain and daily living activities are evaluated by the patient, joint range of motion and strength are evaluated by the clinician. A higher score corresponds to a higher-quality of function. | baseline and after 4 weeks of treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04458480 -
Effect of Fast Inpatient Rehabilitation After TKA
|
||
Recruiting |
NCT06238596 -
Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)
|
N/A | |
Recruiting |
NCT05547152 -
Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03661944 -
Functional Performance Assessments in Overhead Athletes With Shoulder Injury
|
||
Completed |
NCT05875480 -
The Effectiveness of Telerehabilitation After Arthroscopic Meniscus Repair
|
N/A | |
Not yet recruiting |
NCT05854056 -
Tibial Tubercle Distalisation and Accelerated Rehabilitation
|
N/A | |
Not yet recruiting |
NCT05177380 -
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
|
N/A | |
Not yet recruiting |
NCT04419753 -
The Role of Attention Focus Walking Training in Older Adults.
|
N/A | |
Not yet recruiting |
NCT03628495 -
Effectiveness of a Combined Pressure and Silicone Intervention for Hypertrophic Scar Treatment
|
N/A | |
Completed |
NCT02413996 -
Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty
|
N/A | |
Completed |
NCT01205542 -
Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Shoulder Function
|
N/A | |
Completed |
NCT02644096 -
Rehabilitation of Patients After THR - Based on Patients´Selfrated Health
|
Phase 1 | |
Completed |
NCT03582371 -
Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK)
|
N/A | |
Completed |
NCT05655039 -
The Effect of Pre-rehabilitation and Rehabilitation Period on Functional Status in Inpatient Stroke Patients
|
||
Completed |
NCT04502654 -
Rehabilitation for Thoracoscopic Lobectomy
|
||
Completed |
NCT06206018 -
Patient-Reported Outcome Measures in Lower Extremity Rehabilitation Program PROM_R: Impact on Health Care
|
N/A | |
Completed |
NCT03386604 -
Physical Capacity of Patients With Chronic Obstructive Pulmonary Disease With and Without Supplementation of Whey
|
N/A | |
Recruiting |
NCT05619666 -
Acute Rehabilitation in Patients With COVID-19 Pneumonia
|
N/A | |
Completed |
NCT06251791 -
Inspiratory Muscle Training and Expiratory Muscle Thickness
|
N/A |